|

BC008-1A 1200mg Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.1

Indications

  • Advanced Esophageal Cancers1
  • Advanced Non Small Cell Lung Cancer (NSCLC)1
  • Lung Cancer1
  • Cancer1

Other1 trial

Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.